Epistatic interactions involving DRD2, DRD4, and COMT polymorphisms and risk of substance abuse in women with binge-purge eating disturbances
Section snippets
The present study
To date, no study has explored the association between dopaminergic gene variations and substance use in individuals with binge-purge eating syndromes. To fill this knowledge gap, we examined the bearing of variations within the DRD2 Taq1A, DRD4 7R, and COMT polymorphisms upon risk of misuse of alcohol, cannabis, cocaine and stimulants in women with bine-purge eating disorder variants. Although phenomenological differences exist, evidence has shown women with binge-purge or purge-only eating
Participants
All participants in this institutional ethics board approved study provided written informed consent and all received modest monetary compensation for time invested. Participants were recruited through a specialized eating disorders program using the criteria: Body Mass Index (BMI) above 17.5 and below 40, and meeting criteria for Bulimia Nervosa (BN) or Eating Disorder Not Otherwise Specified (EDNOS) with binge eating and/or purging according to the Diagnostic and Statistical Manual of Mental
Results
Table 1 shows genotype frequencies for DRD2, DRD4 and COMT variants. Hardy–Weinberg tests were conducted on observed genotypes and indicated genotype rates to be in equilibrium for DRD2 [χ2 (1) = 2.32, n.s.], COMT [χ2 (1) = 0.139, n.s.] and DRD4 [χ2 (1) = 5.89, n.s.]. For DRD4, we examined rates of carriers of alleles 7 or higher and of alleles 6 or lower--a dichotomization consistent with previous literature (Eisenberg et al., 2007). Table 2a, Table 2b displays percentages of use of substances
Discussion
We examined the extent to which variants of functional polymorphisms of genes acting upon dopamine function differentiated individuals with a binge-purge syndrome who did, or did not, show a lifetime history of substance abuse. Towards this end, we tested for main and interaction effects of three widely studied polymorphisms—DRD2 Taq1 rs1800497, DRD4 7R, and COMT rs4680—with outcomes being lifetime history of cannabis, alcohol, stimulant, cocaine, or “any substance” abuse. Our main findings
Contributors
Howard Steiger was Principal Investigator, responsible for the overall design and management of this project. Lea Thaler supervised data management and performed main data analyses. Ridha Joober supervised the processing of biological samples, DNA extraction and genotyping. Lise Gauvin was statistical and design consultant, and oversaw all aspects of the final data analysis. Mimi Israel contributed to the design of the study and supervised diagnostic interviews. Audrey Kucer was a student who
Role of the funding source
This research was supported by grants awarded to Dr. Steiger and colleagues (nos. MOP-79490 and MOP-57929) from the Canadian Institutes for Health Research. The funding agency had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report, or in the decision to submit the paper for publication.
Conflict of interest
The authors have no conflicts of interest to report.
Acknowledgment
This research was supported by grants awarded to Dr. Steiger and colleagues (nos. MOP-79490 and MOP-57929) from the Canadian Institutes for Health Research. The funding agencies had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report, or in the decision to submit the paper for publication.
The authors are grateful to Emeline Hetroy for assistance in manuscript preparation.
References (44)
- et al.
Reward sensitivity and the D2 dopamine receptor gene: a case-control study of binge eating disorder
Prog. Neuropsychopharmacol. Biol. Psychiatry
(2008) - et al.
COMT met allele differentially predicts risk versus severity of aberrant eating in a large community sample
Psychiatry Res.
(2014) - et al.
Methylation of the dopamine D2 receptor (DRD2) gene promoter in women with a bulimia-spectrum disorder: associations with borderline personality disorder and exposure to childhood abuse
J. Psychiatr. Res.
(2014) - et al.
Dopamine-system genes, childhood abuse, and clinical manifestations in women with Bulimia-spectrum Disorders
J. Psychiatr. Res.
(2012) - et al.
The prevalence and correlates of eating disorders in the national comorbidity survey replication
Biol. Psychiatry
(2007) - et al.
The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective
Biol. Psychiatry
(2004) - et al.
The association of catechol-O- methyltransferase genotype with the phenotype of women with eating disorders
Brain Res.
(2010) - et al.
Reward circuitry responsivity to food predicts future increases in body mass: moderating effects of DRD2 and DRD4
NeuroImage
(2010) - et al.
Epistatic interactions implicating dopaminergic genes in bulimia nervosa (BN): relationships to eating-and personality-related psychopathology
Prog. Neuropsychopharmacol. Biol. Psychiatry
(2012) - et al.
Imaging dopamine's role in drug abuse and addiction
Neuropharmacol
(2009)
Diagnostic and Statistical Manual of Mental Disorders
Catechol-O-methyltransferase activity in erythrocytes from patients with eating disorders
Eat. Weight Disord.-ST
Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants
J. Neurochem.
Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking
Nat. Genet.
Striatal dopamine in bulimia nervosa: a PET imaging study
Int. J. Eat. Disord.
Personality pathology in purging disorder and bulimia nervosa
Int. J. Eat. Disord.
Alcohol use disorder comorbidity in eating disorders: a multicenter study
J. Clin. Psychiatry
The genetics of bulimia nervosa
Drugs. Today
Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study
Behav. Brain Funct.
Eating disorders
Lancet
The eating disorders examination
Structured Clinical Interview for DSM-iv Axis I Disorders (SCID)
Cited by (16)
Epistatic effect of Ankyrin repeat and kinase domain containing 1 – Dopamine receptor D2 and catechol-o-methyltransferase single nucleotide polymorphisms on the risk for hazardous use of alcohol in Lithuanian population
2021, GeneCitation Excerpt :Homozygotes of ANKK1-DRD2 T allele were combined with heterozygotes to evaluate the effect of the presence of the T allele in contrast to the ANKK1-DRD2 CC genotype. For evaluation of the interaction of the COMT rs4680 and ANKK1-DRD2 rs1800497 polymorphisms, six groups were formed as previously described (Steiger et al., 2016; Yacubian et al., 2007): AA × CC (combination of COMT AA and ANKK1-DRD2 CC), AG × CC (combination of COMT AG and ANKK1-DRD2 CC), GG × CC (combination of COMT GG and ANKK1-DRD2 CC), AA × CT/TT (combination of COMT AA and ANKK1-DRD2 CT/TT), AG × CT/TT (combination of COMT AG and ANKK1-DRD2 CT/TT), GG × CT/TT (combination of COMT GG and ANKK1-DRD2 CT/TT). Significances of separate polymorphisms and combinations of genotypes on the risk for hazardous alcohol use were evaluated using the multivariate logistic regression analysis.
Interactions between the combined genotypes of 5-HTTLPR and BDNF Val66Met polymorphisms and parenting on adolescent depressive symptoms: A three-year longitudinal study
2020, Journal of Affective DisordersCitation Excerpt :As such, it is theoretically possible that the joint effects of 5-HTTLPR and BDNF Val66Met polymorphisms may affect individuals’ sensibility to certain environments toward adolescent depressive symptoms. Some researchers are beginning to use two analytic approaches so far for illuminating multiple genetic effects on psychological phenotypes: epistatic and cumulative methods (Pearson et al., 2016; Steiger et al., 2016). The former is defined that the effect of one gene (locus) is dependent on the presence of one or more genes, namely genes interact with each other (Tyler et al., 2009).
Complete sequence of the ANKK1 gene in Mexican-Mestizo individuals with obesity, with or without binge eating disorder
2018, European PsychiatryCitation Excerpt :Furthermore, genetic variations in ANKK1/DRD2 have been reported in patients with obesity and/or BED [15–17]. Taking into consideration that both obesity and BED have a genetic predisposition and that the genetic correlation between both has been determined in different ethnic groups [11,16–18,24], it is important to establish the possible presence of mutations in different populations from different ethnicities, since genomic variation is greater when compared across ethnicities. Therefore, in the present study we analyzed all coding regions of ANKK1 in individuals with obesity, with or without BED, who pertain to a specific ethnic group not studied before.
Risk factors for eating disorders: findings from a rapid review
2023, Journal of Eating Disorders